Infection Diagnostic Articles & Analysis
22 news found
These rigorously validated antigens are suitable for use in HBV mimetics, standard antigens for ELISA, and Western blotting, and are designed to assist researchers in advancing their understanding of HBV infection and developing novel diagnostic methods or more effective antiviral therapies. ...
Because of the clinical importance of rapid laboratory diagnosis, direct detection of viral antigens in nasopharyngeal secretions, feces, or both is used as the primary diagnostic test for adenovirus infection. Immunofluorescence (IF) was the first method used for rapid diagnosis of respiratory infections caused by viruses. ...
Although these viruses infect a variety of cell types, they enter host cells by a conserved mechanism. ...
Traditional influenza virus neutralization assays (based on inhibiting the formation of cytogenetic effects in MDCK cell culture) are time-consuming, laborious, and relatively slow. Creative Diagnostics' new Microneutralization Test provides researchers with high-quality results in two days using the ELISA microtiter plates, covering target virus and infected ...
Currently, the detection of neuraminidase and neuraminidase inhibitors (NIs) utilizing fluorescent neuraminidase assay is a major strategy in studying biological processes and preventing influenza infection. Creative Diagnostics can measure fluorescent substances released by active influenza neuraminidase enzyme. ...
As a consulting and experimental service provider specializing in virology and microbiology, Creative Diagnostics recently introduced CC50/IC50 Assay service with a high level of assay sensitivity and accuracy. ...
Clinicians therefore utilize presumptive treatment, or prescribing treatment for a suspected infection without the benefit of diagnostic results, which can lead to incorrect treatment, under-treatment, or over-treatment which contributes to societal antibiotic resistance. “Sexually transmitted infections are three things: often ...
The main cell types of EBV infection are epithelial cells and B cells. Once the initial lytic infection of EBV is controlled, EBV latency persists in an individual’s B cells for the rest of the individual’s life. EBV-specific serological assays, such as ELISA, EIA, IFA, chemiluminescence, and immunoblot, are the easiest methods to test for EBV ...
Visby Medical, Inc. an innovative diagnostic company, today announced its agreement with Urgent Care for Children (UC4C) to offer the company’s new Sexual Health Click Test to patients for the detection of sexually transmitted infections (STIs) in female patients 14 years of age and older. ...
HiberGene Diagnostics are delighted to be recognised as one of Irelands ‘20 Healthtech innovations to watch in 2022’. ...
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced it has raised $50 million in Series C financing to support the U.S. commercial launch of its Next-Generation Phenotyping (NGP) rapid Antimicrobial Susceptibility Testing (AST) platform. ...
The study demonstrated the test’s high performance in distinguishing between bacterial and viral infection Incorporated a broad pediatric population presenting with fever without source and respiratory tract infection MeMed’s test outperformed existing biomarkers of infection MeMed, a leader in the emerging field of advanced ...
ByMeMed
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced that John Wilson has joined the company as Chief Commercial Officer. ...
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced that it has received a $2.8 million award from the U.S. ...
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced that its Next Generation 'Phenotyping' (NGP) platform has received Breakthrough Device Designation from the U.S. ...
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced that its Next Generation 'Phenotyping' (NGP) platform has received Breakthrough Device Designation from the U.S. ...
While rapid ID instrumentation for blood stream infections is now widely available, clinicians often wait additional 1 to 2 days to receive the AST results required to identify the optimal antibiotic therapy, which the ID result alone does not enable. ...
Kephera Diagnostics announced today the launch of a quantitative test to measure the level of antibodies elicited by vaccination against COVID-19, as well as by COVID-19 infection. ...
To address this important gap, NOI and OUH, with the support of RCN, have now committed themselves to develop an AI-designed T-cell diagnostic that monitors the underlying T-cell response to the infection. ...
Selux Diagnostics, Inc., which is leading a new era in personalized medicine to treat superbug infections and combat antibiotic resistance, today announced that it has been awarded an additional $9.6 million from the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. ...